Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Breast Neoplasms 658Carcinoma, Non-Small-Cell Lung 455Prostatic Neoplasms 385Neoplasms 378Lung Neoplasms 261Multiple Myeloma 249Colorectal Neoplasms 230Neoplasm Metastasis 212Melanoma 201Ovarian Neoplasms 165Leukemia, Myeloid, Acute 162Pancreatic Neoplasms 155Carcinoma, Renal Cell 140Squamous Cell Carcinoma of Head and Neck 137Lymphoma 135Brain Neoplasms 132Leukemia, Lymphocytic, Chronic, B-Cell 128Glioblastoma 126Lymphoma, Non-Hodgkin 124Recurrence 122Carcinoma, Hepatocellular 119Head and Neck Neoplasms 115Urinary Bladder Neoplasms 111Triple Negative Breast Neoplasms 106Stomach Neoplasms 105Precursor Cell Lymphoblastic Leukemia-Lymphoma 103Uterine Cervical Neoplasms 102Hematologic Neoplasms 99Lymphoma, Follicular 95Sarcoma 93

Interventions

Vorinostat 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Anemia, Refractory × 1 year × Clear all
NCT00392353 2026-04-13

Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
135 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡